Dr Suren Kanagasundaram
Dr John Perry
Dr Nicholas Hoenich
Dr Rachael Fraser
| Fluids for continuous renal replacement therapy - an evaluation of microbial integrity | 2015 |
|
Dr Nicholas Hoenich
| Transfer of low-molecular weight single-stranded DNA through the membrane of a high-flux dialyzer | 2014 |
|
Dr Nicholas Hoenich
| Hospitalization and Mortality in Hemodialysis Patients: Association with Hemoglobin Variability | 2013 |
|
Dr Suren Kanagasundaram
Dr Nicholas Hoenich
| Summary of the 5th Edition of the Renal Association Clinical Practice Guidelines (2009-2012) | 2011 |
|
Dr Nicholas Hoenich
| Water for haemodialysis and related therapies: Recent standards and emerging issues | 2010 |
|
Dr Nicholas Hoenich
| Disinfection of the hospital water supply: A hidden risk to dialysis patients | 2009 |
|
Dr Nicholas Hoenich
| How do changes in water quality and dialysate composition affect clinical outcomes? | 2009 |
|
Dr Nicholas Hoenich
| Synthesis and characterization of size-selective nanoporous polymeric adsorbents for blood purification | 2009 |
|
Dr Nicholas Hoenich
| Impact of water quality and dialysis fluid composition on dialysis practice | 2008 |
|
Dr Nicholas Hoenich
| Water treatment for dialysis: Technology and clinical implications | 2008 |
|
Emerita Professor Sally Marshall
Dr Nicholas Hoenich
Dr Michael Thompson
| Advanced glycation end products elicit externalization of phosphatidylserine in a subpopulation of platelets via 5-HT2A/2C receptors | 2007 |
|
Dr Nicholas Hoenich
| Effect of low-flux dialysis on phosphatidylserine externalization in patients with chronic kidney disease and diabetes mellitus | 2007 |
|
Dr Nicholas Hoenich
| Haemodialysis fluid: Composition and clinical importance | 2007 |
|
Dr Nicholas Hoenich
| Hemodialysis machines | 2007 |
|
Dr Nicholas Hoenich
| Membranes and filters for haemodiafiltration | 2007 |
|
Dr Nicholas Hoenich
| Membranes and filters for Haemodiafiltration | 2007 |
|
Dr Nicholas Hoenich
| Membranes for dialysis: Can we do without them? | 2007 |
|
Dr Nicholas Hoenich
| Revisiting the role of flux in β2-microglobulin removal | 2007 |
|
Dr Nicholas Hoenich
| The extracorporeal circuit: Materials, problems, and solutions | 2007 |
|
Emerita Professor Sally Marshall
Dr Nicholas Hoenich
Dr Michael Thompson
| Advanced glycation end products stimulate platelet phosphatidylserine externalisation: a role for 5HT(2A) receptors and protein kinase C delta but not caspase-3 | 2006 |
|
Dr Nicholas Hoenich
| Cellulose for medical applications: past, present and future | 2006 |
|
Dr Nicholas Hoenich
| Hemodialysis apparatus | 2006 |
|
Dr Nicholas Hoenich
| Membranes for renal replacement therapy. Materials and outcomes what is the evidence for a link? | 2006 |
|
Dr Nicholas Hoenich
| The importance of water quality and haemodialysis fluid composition | 2006 |
|
Emerita Professor Sally Marshall
Dr Michael Thompson
Dr Nicholas Hoenich
| Cardiovascular risk in patients with end-stage renal disease: A potential role for advanced glycation end products | 2005 |
|
Dr Nicholas Hoenich
| Clinical waste generation from renal units: Implications and solutions | 2005 |
|
Dr Nicholas Hoenich
| Intradialytic complications: pathophysiology, prevention and treatment | 2005 |
|
Dr Nicholas Hoenich
| Membranes and Permeable Films | 2005 |
|
Dr Nicholas Hoenich
| Structured carbon haemoadsorbents for the removal of middle molecular weight toxins | 2005 |
|
Dr Nicholas Hoenich
| Hemodialyzers and related devices | 2004 |
|
Dr Nicholas Hoenich
| Preparation of novel mesoporous carbons for the adsorption of an inflammatory cytokine (IL-1β) | 2004 |
|
Dr Nicholas Hoenich
| The role of improved water quality on inflammatory markers in patients undergoing regular dialysis | 2004 |
|
Dr Nicholas Hoenich
| Update on the biocompatibility of hemodialysis membranes | 2004 |
|
Dr Nicholas Hoenich
| AGE removal with low flux polymeric hemodialysis membranes | 2003 |
|
Dr Nicholas Hoenich
| Breath ethane in dialysis patients and control subjects | 2003 |
|
Dr Nicholas Hoenich
| Can technology solve the clinical problem of 'dry weight'? | 2003 |
|
Dr Nicholas Hoenich
| Effect of dialysis dose and membrane flux in maintenance hemodialysis [1] (multiple letters) | 2003 |
|
Dr Nicholas Hoenich
| Measurement of intraperitoneal volume by segmental bioimpedance analysis during peritoneal dialysis | 2003 |
|
Dr Nicholas Hoenich
| On-line clearance: a useful tool for monitoring the effectiveness of the reuse procedure | 2003 |
|
Dr Nicholas Hoenich
| Running water: measuring water quality in a dialysis facility. Part 2 | 2003 |
|
Dr Nicholas Hoenich
| Searching for the stone of wisdom (multiple letters) [1] | 2003 |
|
Dr Nicholas Hoenich
| Technological advances in renal care | 2003 |
|
Dr Nicholas Hoenich
| Technological advances in renal care. | 2003 |
|
Dr Nicholas Hoenich
| The Implications of Water Quality in Hemodialysis | 2003 |
|
Dr Nicholas Hoenich
| Ultrapure water can be routinely produced and result in reduction of chronic micro inflammation in HD patients. | 2003 |
|
Dr Nicholas Hoenich
| Accuracy and clinical utility of dialysis dose measurement using online ionic dialysance | 2002 |
|
Dr Nicholas Hoenich
| Biocompatibility of sorbent systems | 2002 |
|
Dr Nicholas Hoenich
| Biocompatibility of sorbent systems | 2002 |
|
Dr Nicholas Hoenich
| Clinical characterization of a new polymeric membrane for use in renal replacement therapy | 2002 |
|
Dr Nicholas Hoenich
| Computerized selection of membranes and hemodialyzers | 2002 |
|
Dr Nicholas Hoenich
| Estimation of dry weight in hemodialysis patients by continous segmental bioimpedance analysis (SBIA). | 2002 |
|
Professor Tim Goodship
Dr Nicholas Hoenich
Timothy Hawkins
Dr Peter Fawcett
Dr John Tapson
et al. | Is decreased treatment time in hemodialysis patients harmful if solute clearance is maintained? | 2002 |
|
Dr Nicholas Hoenich
| Is stepwise profiling of ultrafiltration and sodium beneficial to the elderly patient receiving haemodialysis therapy? | 2002 |
|
Dr Nicholas Hoenich
| Low flux dialysis? Still a role | 2002 |
|
Dr Nicholas Hoenich
| Low flux dialysis? Still a role | 2002 |
|
Dr Nicholas Hoenich
| Medical waste production and disposal arising from renal replacement therapy | 2002 |
|
Dr Nicholas Hoenich
| Very high levels of breath ethane in some diabetic patients on long-term hemodialysis | 2002 |
|
Dr Nicholas Hoenich
| Computerized selection of membranes and hemodialysers | 2001 |
|
Dr Nicholas Hoenich
| Haemodialysis membranes: A matter of fact or taste? | 2001 |
|
Dr Nicholas Hoenich
Dr Christopher Snowden
Professor Derek Manas
Emeritus Professor John Kirby
David Talbot
et al. | Machine perfusion for kidneys: How to do it at minimal cost | 2001 |
|
Dr Nicholas Hoenich
Susan Stamp
| A microdomain-structured synthetic high-flux hollow-fiber membrane for renal replacement therapy | 2000 |
|
Dr Nicholas Hoenich
| Clinical characterisation of polysulfone LS membrane for renal replacement therapy | 2000 |
|
Dr Nicholas Hoenich
Susan Stamp
| Clinical investigation of the role of membrane structure on blood contact and solute transport characteristics of a cellulose membrane | 2000 |
|
Dr Nicholas Hoenich
Susan Stamp
| Clinical performance of a new high-flux synthetic membrane | 2000 |
|
Dr Nicholas Hoenich
| Progress in dialysis technology: membrane selection and patient outcome | 2000 |
|
Dr Nicholas Hoenich
| The management of chronic renal insufficiency in the conservative phase | 2000 |
|
Professor Simon Thomas
Dr Nicholas Hoenich
| Treatment of a case of severe mercuric salt overdose with DMPS (dimercapo-1-propane sulphonate) and continuous haemofiltration | 2000 |
|
Dr Nicholas Hoenich
| Platelet and leucocyte behaviour during haemodialysis | 1999 |
|
Dr Nicholas Hoenich
Dr Chris Redfern
Professor Tim Goodship
| Production of interleukin 1 receptor antagonist and interleukin 1 during haemodialysis with cellulose membranes | 1994 |
|
Dr Nicholas Hoenich
Professor Thomas Lennard
George Proud
Robert Taylor
| Surgical management of long-term central venous access in uraemic patients | 1988 |
|
